Skip to main content

Table 3 Median antifilarial IgG levels for the 126 persons in the Mapou cohort who received antifilarial drug treatment in 2000 and the 34 who did not, by year

From: Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence

   Antifilarial Antibody Level*
Treatment status   2000 2001  
Received treatment   Median (interquartile range) Median (interquartile range) p-value
  IgG1 68.5 (22.2–147.5) 43.0 (20.9–85.6) 0.001
  IgG4 57.5 (29.9–98.3) 55.9 (21.0–65.9) 0.067
Did not receive treatment     
  IgG1 64.5 (31.9–157.0) 100.0 (52.3–169.7) 0.101
  IgG4 61.5 (45.6–104.6) 96.4 (52.40–216.0) 0.088
  1. *units